(NRBO) Stock Quotes, Forecast and News Summary

NRBO stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	- / -
Day Range	- - -
52 Wk Range	- - -
Market Cap	-
P/E Ratio	-
Dividend Yield	-
Exchange
RSI	0
Short Interest	-
Days to Cover	1

Recent News

NeuroBo Pharmaceuticals And 2 Other Penny Stocks Insiders Are Buying

Avi Kapoor

NeuroBo Pharmaceuticals Stock Slides Despite Animal Study Showing Wegvoy, Liver Fibrosis Success

NeuroBo says DA-1241 data shows improved liver fibrosis and additive hepatoprotective effects when combined with semaglutide.

Vandana Singh

Dow Jumps 250 Points; Honeywell Issues Weak Forecast

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 250 points on Thursday. The Dow traded up 0.66% to 38,403.91 while the NASDAQ rose 1.01% to 15,316.80. The S&P 500 also rose, gaining, 0.87% to 4,887.70.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	- / -
Day Range	- - -
52 Wk Range	- - -
Market Cap	-
P/E Ratio	-
Dividend Yield	-
Exchange
RSI	0
Short Interest	-
Days to Cover	1

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

Comments

(NRBO) Forecast

(NRBO) Stock Quotes, Forecast and News Summary

Recent News

Financials

Analyst Rating and Forecast

Compare

FAQ

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga